Return
Correction to: Should Incretin Agonist-Based Drugs be Considered for First Line Antihypertensive Therapy?
D
L
U
DOI:10.1007/s11906-026-01377-4.png)
Abstract
En
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
5.1
Papers:
1.9K
Citations:
5.0K
